Llorenç V - Search Results

1

Antimetabolite Drugs Exhibit Distinctive Immunomodulatory Mechanisms and Effects on the Intestinal Microbiota in Experimental Autoimmune Uveitis.

Llorenç V, Nakamura Y, Metea C, Karstens L, Molins B, Lin P. Llorenç V, et al. Invest Ophthalmol Vis Sci. 2022 Mar 2;63(3):30. doi: 10.1167/iovs.63.3.30. Invest Ophthalmol Vis Sci. 2022. PMID: 35357394 Free PMC article.

2

Dexamethasone intravitreal implant for treatment of uveitic persistent cystoid macular edema in vitrectomized patients.

Adán A, Pelegrín L, Rey A, Llorenç V, Mesquida M, Molins B, Ríos J, Keller J. Adán A, et al. Among authors: llorenc v. Retina. 2013 Jul-Aug;33(7):1435-40. doi: 10.1097/IAE.0b013e31827e247b. Retina. 2013. PMID: 23514796

3

Clinical pattern of toxoplasmic retinochoroiditis in a Spanish referral center.

Rey A, Llorenç V, Pelegrín L, Mesquida M, Molins B, Rios J, Arévalo JF, Adán A. Rey A, et al. Among authors: llorenc v. Ophthalmologica. 2013;229(3):173-8. doi: 10.1159/000348740. Epub 2013 Mar 27. Ophthalmologica. 2013. PMID: 23548496

4

Lack of association between the protein tyrosine phosphatase non-receptor type 22 R263Q and R620W functional genetic variants and endogenous non-anterior uveitis.

Cénit MC, Márquez A, Cordero-Coma M, Fonollosa A, Llorenç V, Artaraz J, Díaz Valle D, Blanco R, Cañal J, Salom D, García Serrano JL, de Ramón E, José del Rio M, Gorroño-Echebarría MB, Martín-Villa JM, Molins B, Ortego-Centeno N, Martín J. Cénit MC, et al. Among authors: llorenc v. Mol Vis. 2013;19:638-43. Epub 2013 Mar 20. Mol Vis. 2013. PMID: 23559857 Free PMC article.

5

Current and future treatments for Behçet's uveitis: road to remission.

Mesquida M, Molins B, Llorenç V, Hernández MV, Espinosa G, Dick AD, Adán A. Mesquida M, et al. Among authors: llorenc v. Int Ophthalmol. 2014 Apr;34(2):365-81. doi: 10.1007/s10792-013-9788-5. Epub 2013 Jun 1. Int Ophthalmol. 2014. PMID: 23729309 Review.

6

Cytokine profiling reveals decreased serum levels of CCL2 in active ocular toxoplasmosis.

Rey A, Molins B, Llorenç V, Pelegrín L, Mesquida M, Adán A. Rey A, et al. Among authors: llorenc v. Br J Ophthalmol. 2013 Oct;97(10):1338-42. doi: 10.1136/bjophthalmol-2013-303092. Epub 2013 Jul 22. Br J Ophthalmol. 2013. PMID: 23878135

7

Tocilizumab treatment for refractory uveitis-related cystoid macular edema.

Adán A, Mesquida M, Llorenç V, Espinosa G, Molins B, Hernández MV, Pelegrín L. Adán A, et al. Among authors: llorenc v. Graefes Arch Clin Exp Ophthalmol. 2013 Nov;251(11):2627-32. doi: 10.1007/s00417-013-2436-y. Epub 2013 Jul 27. Graefes Arch Clin Exp Ophthalmol. 2013. PMID: 23893042

8

Proinflammatory cytokines and C-reactive protein in uveitis associated with Behçet's disease.

Mesquida M, Molins B, Llorenç V, Sainz de la Maza M, Hernandez MV, Espinosa G, Adán A. Mesquida M, et al. Among authors: llorenc v. Mediators Inflamm. 2014;2014:396204. doi: 10.1155/2014/396204. Epub 2014 Jun 8. Mediators Inflamm. 2014. PMID: 24994946 Free PMC article.

9

Long-term effects of tocilizumab therapy for refractory uveitis-related macular edema.

Mesquida M, Molins B, Llorenç V, Sainz de la Maza M, Adán A. Mesquida M, et al. Among authors: llorenc v. Ophthalmology. 2014 Dec;121(12):2380-6. doi: 10.1016/j.ophtha.2014.06.050. Epub 2014 Sep 6. Ophthalmology. 2014. PMID: 25204610

10

Regulatory T cell levels and cytokine production in active non-infectious uveitis: in-vitro effects of pharmacological treatment.

Molins B, Mesquida M, Lee RW, Llorenç V, Pelegrín L, Adán A. Molins B, et al. Among authors: llorenc v. Clin Exp Immunol. 2015 Mar;179(3):529-38. doi: 10.1111/cei.12479. Clin Exp Immunol. 2015. PMID: 25354724 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

89 results

Search Page

Filters